Loading stock data...

Dishman Carbogen Amcis Limited

NSE: DCAL BSE: DCAL

NSE
229.20 12.74 (5.89%)

Prev Close

216.46

Open Price

233.85

Volume

376,627

Today Low / High

219 / 233.85

52 WK Low / High

178 / 321.95

Range

218 - 241

BSE
231.15 15.75 (7.31%)

Prev Close

215.4

Open Price

225

Volume

12,478

Today Low / High

220 / 233.5

52 WK Low / High

180 / 321.15

Range

220 - 243

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 229.2 (target range: 218 - 241), reflecting a change of 12.74 (5.88561%). On the BSE, it is listed at 231.15 (target range: 220 - 243), showing a change of 15.75 (7.31198%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

03 Feb 233.85 -2.02%
02 Feb 214.78 0.78%
01 Feb 217.40 -1.21%
30 Jan 205.50 6.31%
29 Jan 204.87 0.37%
28 Jan 204.40 0.36%
27 Jan 208.00 -2.37%
23 Jan 219.70 -4.72%
22 Jan 221.10 -1.21%
21 Jan 228.60 -4.72%
20 Jan 242.66 -5.75%
19 Jan 254.08 -3.98%
16 Jan 253.50 0.23%
14 Jan 261.00 -2.64%
13 Jan 259.80 1.36%
12 Jan 258.18 0.75%
09 Jan 256.02 0.77%
08 Jan 263.20 -1.58%
07 Jan 259.20 1.48%
06 Jan 254.87 0.73%

Dishman Carbogen Amcis Limited Graph

Dishman Carbogen Amcis Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Dishman Carbogen Amcis Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 229.20, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 231.15 233.46 210.12 - 256.81
235.77 188.62 - 282.93
238.08 166.66 - 309.51
Bearish Scenario 231.15 228.84 205.95 - 251.72
226.53 181.22 - 271.83
224.22 156.95 - 291.48

Overview of Dishman Carbogen Amcis Limited

ISIN

INE385W01011

Industry

Biotechnology

Vol.Avg

258,517

Market Cap

35,934,685,374

Last Dividend

0

Official Website

Visit Website

IPO Date

2004-04-22

DCF Diff

422.62

DCF

-197

Financial Ratios Every Investor Needs

Stock Dividend of DCAL

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2019-09-12 September 12, 19 0.2 0.2 2019-09-13 2019-10-24 2019-05-15
2017-02-17 February 17, 17 1.2 1.2 2017-02-21 2017-03-01
2016-03-17 March 17, 16 1 2
2015-09-10 September 10, 15 1 2
2014-08-21 August 21, 14 0.6 1.2

Stock Rating Details for DCAL

Metric Value Recommendation
Overall Rating B- Neutral
DCF Score 1 Strong Sell
ROE Score 3 Neutral
ROA Score 3 Neutral
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 2,711.50 Cr 501.65 Cr 2,209.85 Cr 0.8150 0.00 Cr 1,296.17 Cr 175.20 Cr 3.24 Cr 0.21 472.51 Cr 0.0012
2024-03-31 2,615.77 Cr 771.16 Cr 1,844.61 Cr 0.7052 12.98 Cr 114.42 Cr -80.28 Cr -153.45 Cr -9.79 307.18 Cr -0.0587
2023-03-31 2,315.05 Cr 534.21 Cr 1,780.84 Cr 0.7692 0.00 Cr 100.34 Cr 105.49 Cr -29.80 Cr -1.90 307.62 Cr -0.0129
2022-03-31 2,140.68 Cr 458.88 Cr 1,681.80 Cr 0.7856 13.90 Cr 72.16 Cr 29.85 Cr 18.01 Cr 1.15 342.56 Cr 0.0084
2021-03-31 1,912.03 Cr 484.09 Cr 1,427.94 Cr 0.7468 6.50 Cr 63.09 Cr -12.35 Cr -165.13 Cr -10.53 286.42 Cr -0.0864

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 507.03 Cr 9,999.15 Cr 4,167.63 Cr 5,831.5200 Cr 2,388.95 Cr 1,881.92 Cr 900.24 Cr 3,171.08 Cr 0.00 Cr 0.00 Cr 104.08 Cr 1,924.7900 Cr
2024-03-31 264.09 Cr 9,581.41 Cr 3,953.91 Cr 5,627.5000 Cr 2,312.60 Cr 2,048.51 Cr 882.89 Cr 3,236.14 Cr 0.00 Cr 446.38 Cr 8.57 Cr 2,554.7200 Cr
2023-03-31 131.79 Cr 9,453.50 Cr 3,643.83 Cr 5,809.6700 Cr 2,208.85 Cr 2,077.06 Cr 803.80 Cr 3,234.70 Cr 429.65 Cr 165.12 Cr -131.56 Cr 1,798.3900 Cr
2022-03-31 110.24 Cr 8,637.45 Cr 3,088.51 Cr 5,548.9400 Cr 1,829.89 Cr 1,719.65 Cr 645.12 Cr 2,786.88 Cr 294.58 Cr 126.50 Cr -312.27 Cr 1,419.7900 Cr
2021-03-31 243.54 Cr 8,366.10 Cr 2,667.28 Cr 5,698.8200 Cr 1,588.85 Cr 1,345.31 Cr 515.65 Cr 2,628.09 Cr 0.00 Cr -0.01 Cr -131.20 Cr 1,290.2900 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 375.2300 Cr -192.2100 Cr -102.0900 Cr 158.4700 Cr 76.9800 Cr 341.0700 Cr -216.7600 Cr 19.3100 Cr 78.7900 Cr 0.0000 Cr -24.4700 Cr
2024-03-31 383.9700 Cr -229.5200 Cr -22.1500 Cr 80.7200 Cr 132.3000 Cr 264.0900 Cr -303.2500 Cr -153.4500 Cr 119.2600 Cr 0.0000 Cr -85.2400 Cr
2023-03-31 265.9500 Cr -494.0800 Cr 249.6700 Cr -353.7300 Cr 21.5500 Cr 131.7900 Cr -619.6800 Cr -54.5900 Cr 354.9100 Cr 0.0000 Cr -158.6800 Cr
2022-03-31 354.8500 Cr -618.5300 Cr 130.3700 Cr -108.9500 Cr -133.3000 Cr 110.2400 Cr -463.8000 Cr -4.2500 Cr 216.8200 Cr 0.0000 Cr -143.3000 Cr
2021-03-31 512.6600 Cr -380.7900 Cr -11.0400 Cr 146.6300 Cr 121.6000 Cr 243.5400 Cr -366.0300 Cr -65.0300 Cr 102.4600 Cr 0.0000 Cr 90.9100 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 652.65 Cr 451.38 Cr 201.27 Cr 0.3084 64.76 Cr 65.27 Cr 4.16 157.00 Cr 0.1000
2025-06-30 708.05 Cr 98.09 Cr 609.96 Cr 0.8615 59.33 Cr 23.41 Cr 1.49 162.78 Cr 0.0331
2025-03-31 716.34 Cr 145.91 Cr 570.43 Cr 0.7963 73.60 Cr 43.09 Cr 2.75 148.91 Cr 0.0602
2024-12-31 682.34 Cr 98.83 Cr 583.51 Cr 0.8552 68.16 Cr 4.63 Cr 0.30 147.80 Cr 0.0068
2024-09-30 789.04 Cr 190.56 Cr 598.48 Cr 0.7585 75.06 Cr 33.09 Cr 2.11 150.84 Cr 0.0419

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 615.71 Cr 15.73 Cr 631.44 Cr 659.16 Cr 1,027.67 Cr 2,442.58 Cr 3,386.36 Cr 11,109.14 Cr 4,744.18 Cr
2025-06-30 0.00 Cr 0.00 Cr 532.46 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -5,831.52 Cr
2025-03-31 507.03 Cr 25.43 Cr 532.46 Cr 668.77 Cr 900.24 Cr 2,200.42 Cr 3,171.08 Cr 9,999.15 Cr 4,167.63 Cr
2024-12-31 0.00 Cr 0.00 Cr 416.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -5,736.76 Cr
2024-09-30 228.40 Cr 24.70 Cr 430.49 Cr 710.03 Cr 903.90 Cr 2,144.44 Cr 3,320.22 Cr 10,180.45 Cr 4,443.69 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 23.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 43.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 4.63 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 33.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -77.57 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2016-05-02 May 02, 16 2:1
2005-10-21 October 21, 05 5:1

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹372.00 ₹479,555,187,828.00 ₹4,837,860.00
Anthem Biosciences Ltd. ANTHEM ₹609.00 ₹342,020,521,059.00 ₹264,470.00
Piramal Pharma Limited PPLPHARMA ₹161.09 ₹213,181,252,211.00 ₹3,828,538.00
Syngene International Limited SYNGENE ₹476.40 ₹191,394,549,898.00 ₹1,991,388.00
Onesource Specialty Pharma Ltd. ONESOURCE ₹1,180.30 ₹135,244,840,742.00 ₹394,478.00
Concord Biotech Limited CONCORDBIO ₹1,168.00 ₹122,191,726,272.00 ₹139,750.00
Jubilant Ingrevia Limited JUBLINGREA ₹666.00 ₹105,235,249,410.00 ₹363,399.00
Blue Jet Healthcare Limited BLUEJET ₹422.00 ₹73,202,409,350.00 ₹500,633.00
Supriya Lifescience Limited SUPRIYA ₹693.20 ₹55,790,676,960.00 ₹157,591.00
Zota Health Care Limited ZOTA ₹1,291.10 ₹39,162,490,871.00 ₹40,302.00
Dishman Carbogen Amcis Limited DCAL ₹229.20 ₹35,934,685,374.00 ₹376,627.00

Key Executives

Chief Technology Officer of CARBOGEN AMCIS
Alan Fischer

Gender: Not Specified

Year Born:

Chief Executive Officer of Projects & Operations
Himani S. Dhotre

Gender: Not Specified

Year Born:

Chief Quality & Compliance Officer of CARBOGEN AMCIS
Martin Schneider

Gender: Not Specified

Year Born: 1959

Marketing Manager
Lucie Framinet

Gender: Not Specified

Year Born:

Global MD & Director
Arpit Janmejay Vyas

Gender: male

Year Born: 1986

GM of Secretarial & Legal
Dharmesh Desai

Gender: male

Year Born:

Global Chief Financial Officer
Harshil R. Dalal

Gender: male

Year Born:

Chief Operating Officer of Indian Operations
Paolo Armanino

Gender: male

Year Born:

Whole Time Director
Deohooti Janmejay Vyas

Gender: female

Year Born: 1951

Compliance Officer & Company Secretary
Shrima Gaurangbhai Dave

Gender: female

Year Born:

FAQs about Dishman Carbogen Amcis Limited

Who is the CEO of the company?

The CEO is Himani S. Dhotre.

What is the current market price of the stock?

The current price is ₹229.20.

What is the 52-week price range?

The range is ₹178-321.95.

What is the market capitalization of the company?

The market capitalization is ₹3,593.47 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 26.35.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Dishman Carbogen Amcis Limited (ISIN: INE385W01011) is a leading Biotechnology in India. With a market capitalization of ₹3,593.47 crores and an average daily volume of 258,517 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.